Karuna Therapeutics, Inc. - Common Stock (NQ:KRTX)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Mar 15, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Karuna Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

What 9 Analyst Ratings Have To Say About Karuna Therapeutics ↗

September 28, 2023

Via Benzinga

Karuna Therapeutics Submits New Drug Application to U.S. Food and Drug Administration for KarXT for the Treatment of Schizophrenia

September 28, 2023

From Karuna Therapeutics, Inc.

Via Business Wire

Analyst Expectations for Karuna Therapeutics's Future ↗

September 08, 2023

Via Benzinga

Karuna Therapeutics to Present at Upcoming Investor Conferences

August 30, 2023

From Karuna Therapeutics, Inc.

Via Business Wire

10 Analysts Have This to Say About Karuna Therapeutics ↗

August 22, 2023

Via Benzinga

The Latest Analyst Ratings for Karuna Therapeutics ↗

August 04, 2023

Via Benzinga

The Latest Analyst Ratings for Karuna Therapeutics ↗

July 13, 2023

Via Benzinga

Where Karuna Therapeutics Stands With Analysts ↗

June 01, 2023

Via Benzinga

The Latest Analyst Ratings for Karuna Therapeutics ↗

May 16, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 22, 2023 ↗

August 22, 2023

Via Benzinga

Karuna Therapeutics Reports Second Quarter 2023 Financial Results and Provides General Business Updates

August 03, 2023

From Karuna Therapeutics, Inc.

Via Business Wire

Karuna Therapeutics Announces Leadership Appointments

August 03, 2023

From Karuna Therapeutics, Inc.

Via Business Wire

Karuna Therapeutics's Return On Capital Employed Overview ↗

May 12, 2023

Via Benzinga

3 Biotech Buyout Targets to Watch ↗

April 29, 2023

The trio all have late-stage therapies with blockbuster potential.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2023 ↗

July 20, 2023

Via Benzinga

Karuna Therapeutics to Announce Second Quarter 2023 Financial Results and Provide General Business Update on Thursday, August 3, 2023

July 20, 2023

From Karuna Therapeutics, Inc.

Via Business Wire

Why Shares of Karuna Therapeutics Were Up Wednesday ↗

March 22, 2023

The clinical-stage biotech announced positive trial results for its lead therapy.

Via The Motley Fool

What Are Latest Investor Thoughts On Karuna Therapeutics? Analyst Sees Buying Opportunity ↗

July 14, 2023

William Blair notes increasing investor inbounds on Karuna Therapeutics Inc (NASDAQ: KRTX) given the recent pullback, as the stock is down 13% off June 2023 highs and 25% off 52-week highs

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

July 06, 2023

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

June 29, 2023

Via Benzinga

Karuna Therapeutics to Present at the Goldman Sachs 44th Annual Global Healthcare Conference

May 30, 2023

From Karuna Therapeutics, Inc.

Via Business Wire

Karuna Therapeutics to Present Data from the EMERGENT Program Evaluating KarXT in Schizophrenia at the American Society of Clinical Psychopharmacology Annual Meeting

May 22, 2023

From Karuna Therapeutics, Inc.

Via Business Wire

Royalty Pharma Reaffirms FY23 Guidance Post Mixed Q1 Performance ↗

May 09, 2023

Via Benzinga

Karuna Therapeutics Reports First Quarter 2023 Financial Results and Provides General Business Updates

May 04, 2023

From Karuna Therapeutics, Inc.

Via Business Wire

Karuna Therapeutics to Present at Upcoming Investor Conferences

May 02, 2023

From Karuna Therapeutics, Inc.

Via Business Wire

PureTech Health FY22 Revenue Declines 10.2% YoY, Here Are The Details ↗

April 28, 2023

PureTech Health plc (NASDAQ: PRTC) (LSE:PRTC) released its results for the year ended December 31, 2022, revealing revenue of $15.6 million, a decrease of 10.2% compared to $17.4 million in 2021....

Via Benzinga

Karuna Therapeutics to Announce First Quarter 2023 Financial Results and Provide General Business Update on Thursday, May 4, 2023

April 20, 2023

From Karuna Therapeutics, Inc.

Via Business Wire

Karuna Therapeutics Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares

March 24, 2023

From Karuna Therapeutics, Inc.

Via Business Wire

Karuna Therapeutics to Present at the Stifel 2023 CNS Days

March 23, 2023

From Karuna Therapeutics, Inc.

Via Business Wire

Why Edible Garden Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

March 22, 2023

Gainers Maxpro Capital Acquisition Corp. (NASDAQ: JMAC) shares jumped 69.6% to $15.01 after dropping 24% on Tuesday.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.